As the opioid addition crisis becomes increasingly worse across the U.S. over the past several years, federal policy changes are being implemented to shift patient evaluations toward a virtual format. A focus on buprenorphine, an effective treatment for opioid disorder, was another major aspect of these policy changes, as it is easy to prescribe in a telemedicine setting. Researchers at the ÌìÃÀÓ°ÊÓ´«Ã½ are exploring whether these changes in policy are affecting the disproportionate access to buprenorphine experienced by…
UW study assesses disproportionate access to opioid addiction treatment









